BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

ARTV

No price yet

Announcements

Nothing here yet

Daily updates

  • Artiva to Present Updated AlloNK Data in Refractory Rheumatoid Arthritis at ACR Convergence on November 9, 2026Oct 18, 2026

FDA designations

Nothing here yet

News

  • Artiva Biotherapeutics announces an oral presentation of AlloNK clinical data at the 17th International Symposium on Sjögren's DiseaseSep 23, 2026
  • Artiva announces initial safety and translational data supporting deep B‑cell depletion with AlloNK in autoimmune diseaseNov 12, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy